Psoriasis: The Poster Child for Bench-to-bedside Translational Medicine

Lotus Mallbris1, Brian J Nickoloff1

  • 1Eli Lilly and Company, Indianapolis, Indiana.

Insights

Psoriasis research exemplifies successful translational medicine, improving patient well-being beyond skin lesions. This cycle of collaboration highlights dermatology

Area of Science:

  • Dermatology and immunology research
  • Translational medicine in clinical practice

Background:

  • The skin, as the largest organ, offers unique opportunities for studying immune responses.
  • Translational medicine involves a bidirectional exchange between basic research and clinical practice.
  • Patient-reported outcomes and well-being are increasingly important in dermatological studies.

Purpose of the Study:

  • To highlight the successful translational cycle in psoriasis research.
  • To showcase the collaborative efforts between patients, clinicians, and industry.
  • To underscore the potential of dermatology research in advancing translational medicine.

Main Methods:

  • Review of interactions within psoriasis research.
  • Analysis of bench-to-bedside and bedside-to-bench approaches.
  • Focus on patient-centric outcomes and well-being.

Main Results:

  • Psoriasis research serves as a model for personalized cancer therapy.
  • Successful collaboration between psoriasis patients, dermatologists, immunologists, and the pharmaceutical industry.
  • Significant advancements in understanding and treating psoriasis.

Conclusions:

  • Psoriasis research demonstrates the power of translational medicine in dermatology.
  • Lessons learned from psoriasis studies indicate a promising future for translational research.
  • The collaborative model can enhance patient lives and well-being.